International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 1 | Views: 106 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Study Papers | Obstetrics and Gynecology | India | Volume 12 Issue 3, March 2023


Efficacy of Levonorgestrel Releasing Intrauterine System (Mirena) in Conservative Management of Abnormal Uterine Bleeding

Dr. K. Sreeja | Dr. K. Srujana | Dr. Yalla Annapoorna [3]


Abstract: Background: To study the efficacy of levonorgestrel intrauterine system (LNG-IUS; Mirena) in conservative management of abnormal uterine bleeding (AUB). Objective: To determine the effectiveness of Levonorgestrel releasing intrauterine system (Mirena), in decreasing the menstrual blood loss, dysmenorrhea and dyspareunia at the end of one year after insertion. Materials & Methodology: This observational study was carried out on 43patients done in tertiary care hospital,Rajahmundry over 1 year between 2021 to 2022. A detailed general, systemic, pelvic (to see for Mirena threads), and breasts examination was done at every visit. Follow-up ultrasound was done at every visit to see forMirena location and if there were any changes in the original pelvic pathology or development of a new pathology like ovarian cysts. Hemoglobin (Hb) estimation was done after 1 year. Results: Out of 43 patients studied most common reason for mirena insertion being AUB (53.4%), endometriosis (23.2%), adenomyosis (13.9%) and fibroid uterus (9.30%). Common symptoms for mirena insertion being menorrhagia(62.7%), dysmenorrhea 13 ( 30.2 %) and dyspareunia 3( 6.9%).The majority of women having irregular cycles (74.41%), regular cycles ( 25.58 %).The patterns of bleeding post mirena insertion was shifted to amenorrhea( 48.8%) followed by regularized cycle with reduced flow (37.20% )and irregular cycles with reduced flow (13.9%) The major side effect noticed post mirena insertion is weight gain in 55.8% followed by spotting ( 30.2 %) ,breast tenderness ( 9.3 %) and pelvic pain (4.6%) Conclusion: Levonorgestrel-releasing intrauterine systemna provides an incredible nonsurgical alternative in treatment of abnormal uterine bleeding, adenomyosis, endometriosis, endometrial hyperplasia.Its effects are reversible and it also an effective contraceptive. Side effects are generally mild and most of the times assurance is enough to ensure continuation of device.


Keywords: Abnormal uterine bleeding, mirena, contraceptive, anemia


Edition: Volume 12 Issue 3, March 2023,


Pages: 356 - 359


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top